Pharmacology of N-(3,5-dichloro-1-oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quinoline carboxamide (SCH 351591), a novel, orally active phosphodiesterase 4 inhibitor.

Cite this paper

@article{Billah2002PharmacologyON, title={Pharmacology of N-(3,5-dichloro-1-oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quinoline carboxamide (SCH 351591), a novel, orally active phosphodiesterase 4 inhibitor.}, author={Motasim M Billah and Nicola S Cooper and Michael Minnicozzi and Julie B H Warneck and Peng Wang and John A. Hey and William Kreutner and Charles A Rizzo and Sidney R. Smith and Simon S. Young and Richard W. Chapman and Hazel J Dyke and Nang-Yang Shih and John J. Piwinski and Francis M Cuss and John G. Montana and Ashit K. Ganguly and Robert W. Egan}, journal={The Journal of pharmacology and experimental therapeutics}, year={2002}, volume={302 1}, pages={127-37} }